Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection

NCT03158077 · clinicaltrials.gov ↗
COMPLETED
Status
467
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fundacion SEIMC-GESIDA